Dr Reddy's Laboratories

2026 & beyond: Indian pharma hinges hopes on innovation impetus & regulatory agility

The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, collaborations, digital…

Updated: December 25, 2025 17:39 IST

stocks to watch today, market news December 1, Indian stock market updates

From SAIL, JSW Energy to Paytm, Electronics – Here are 9 stocks to watch

Track key stock moves for SAIL, JSW Energy, Paytm, and more amid major corporate developments—explore today’s top market highlights.

December 15, 2025 06:30 IST

Nifty today, stock market outlook, Monday watchlist,

Monday Watchlist: TCS, Sun Pharma & 7 stocks to watch as Nifty pauses at record levels

Track TCS, Sun Pharma, and sector leaders as Nifty eyes higher targets; spot key stocks for your Monday investment moves…

December 1, 2025 05:30 IST

3 Defensive Bets to Consider for Your 2026 Portfolio

Explore 3 top defensive stocks for your 2026 portfolio to balance risk and stability—find out which companies to watch now!

Updated: December 4, 2025 12:36 IST

MCX Bharti Airtel Waaree Energies NTPC Green market movers India

From Bharti Airtel, BEL, Swiggy to Dr Reddy’s Lab – Here are 10 stocks to watch

Stocks to watch today, November 25: GIFT Nifty indicates a positive start for domestic indices. Here are the top stocks…

November 25, 2025 06:24 IST

JM Financial picks Mahindra & Mahindra, Eternal (Zomato), and Dr Reddy's Laboratories

3 Buy recommendations by JM Financial, with up to 50% upside potential

Discover JM Financial’s 3 top stock picks with up to 50% upside—read their latest analysis and take advantage of these…

November 24, 2025 16:17 IST

The Trump effect: How Indian pharma’s ‘beyond US’ bet is finally paying off

Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…

November 11, 2025 05:30 IST

10 stocks with up to 22% upside – Top brokerage Buys this week

Discover 10 top brokerage stock picks with up to 22% upside this week—see which shares could boost your portfolio now!

November 1, 2025 08:00 IST

Dr Reddy’s Laboratories reported a 6.36 per cent YoY profit growth in the second quarter

Dr Reddy’s Q2 FY26 profit rises 6% YoY to Rs 1,426 crore; revenue up 9%

Dr Reddy’s Q2 FY26 profit rises 6% YoY to ₹1,426 crore; revenue up 9% to Rs 8,805 crore, but margins…

October 24, 2025 17:32 IST

From Infosys, Tata Motors to LTIMindtree, Punjab National Bank – Here are 11 stocks to watch today

Track top stocks like Infosys, Tata Motors, LTIMindtree, PNB, and more as Dalal Street opens for an eventful trading day—see…

October 23, 2025 06:30 IST

From Vedanta, Adani Power to RailTel, Aditya Birla Capital – Here are 11 stocks to watch today

Track key stocks like Vedanta, Adani Power, RailTel, and Aditya Birla Capital as major announcements drive market action today—see the…

September 15, 2025 06:30 IST

Trump’s tariff threats are spooking pharma. Are MNC stocks the answer?

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…

August 19, 2025 15:49 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…

August 11, 2025 16:58 IST

Dr Reddy's Q1 results 2025, Dr Reddy's earnings Q1FY25, Dr Reddy's profit and revenue Q1, Dr Reddy's quarterly results July 2025, Dr Reddy's share price after Q1 results, Dr Reddy's financial performance Q1FY25, Indian pharma earnings Q1FY25, and Dr Reddy's stock news today

Dr Reddy’s Q1FY26: Profit below estimates; revenue up 11.4%- Key 5 takeaways

Dr Reddy’s Q1FY26: Profit below estimates at 1.26%; revenue up 11.4%.

Updated: July 23, 2025 18:55 IST

The big movers in trade today: A look at top 5 gainers on Nifty

Zomato leads Nifty gainers with a 5% rally; explore full list of top market movers now!

June 5, 2025 16:51 IST

Dr Reddy’s Laboratories, cancer drug, Keytruda, partnership, Alvotech, biosimilar, license agreement, manufacturing

Dr Reddy’s, Alvotech partner to develop and commercialize biosimilar of cancer drug Keytruda

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda…

Updated: June 5, 2025 10:29 IST

From Vodafone Idea, BEL, Divi’s Lab to Premier Energies- Here are 8 stocks to watch

Stocks to watch today, May 19: GIFT Nifty indicates a positive start for domestic indices. Here are top stocks to…

May 19, 2025 06:25 IST

Dr Reddy’s Q4 Results: Profit rises by 21% to Rs 1,587 crore on strong sales

Dr Reddy’s posted consolidated net profit growth of 21 per cent year-on-year to Rs 1,587 crore during the March quarter,…

May 9, 2025 18:27 IST

Related News

US tourist visa: B1/B2 visa approved, officer tells applicant ‘we need people like you’

e-Passport launched in India: Who can apply, how to apply, application fee, benefits, and key security upgrades

green card holders, US citizens, Naturalization test, Naturalization civics test, Naturalization eligibility conditions,

US revises the naturalization test all green card holders must pass to become US citizens

From Zoho’s Sridhar Vembu to Google CEO Sundar Pichai: Why top tech leaders are talking about rise of Vibe Coding

Zoho founder Sridhar Vembu to Google CEO Sundar Pichai: Why top tech leaders are talking about rise of Vibe Coding

Jefferies top 3 banking sector picks HDFC Bank Bandhan Bank AU Small Finance Bank

Jefferies’ top 3 banking sector picks with up to 38% upside potential

Pilots’ body flags rostering concerns at Air India Express

Business2 hr ago

ALPA-India has expressed concerns about Air India Express’s pilot rostering practices, citing irregularities that could cause fatigue and stress among cockpit crew. The issue has caused dissatisfaction among pilots during the integration process with AIX Connect.

View all shorts